Combined Optokinetic Stimulation and Cueing-based Reading Therapy to Treat Hemispatial Neglect Following Stroke
Launched by UNIVERSITY OF LUEBECK · Feb 13, 2020
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
see above
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • a first-time stroke in the right hemisphere (confirmed by cranial CT or MRI) within the last six months,
- • a left-sided hemispatial neglect (as detected in at least one subtest of the neuropsychological test battery at screening),
- • the ability to read and understand German language and
- • the ability to give informed consent.
- Exclusion Criteria:
- • dementia
- • other structural brain lesions besides the unilateral stroke (e.g. multiple or bilateral stroke lesions, hydrocephalus, inflammatory lesions, etc.)
- • low vision (corrected \<0.7) due to ophthalmological diseases
About University Of Luebeck
The University of Lübeck is a renowned academic institution in Germany, recognized for its commitment to advancing medical research and education. With a strong focus on innovative clinical trials, the university leverages its interdisciplinary expertise to explore novel therapeutic approaches and enhance patient care. The institution fosters collaboration among researchers, clinicians, and industry partners, ensuring a robust framework for conducting high-quality studies. Through its clinical trial initiatives, the University of Lübeck aims to translate scientific discoveries into tangible health solutions, contributing to the global advancement of medical knowledge and practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Luebeck, Schleswig Holstein, Germany
Patients applied
Trial Officials
Bjoern Machner, MD
Principal Investigator
University of Luebeck
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials